By targeting three pathways, it suppresses appetite, improves glucose control and boosts calorie burning more effectively than current simple or dual agonists
The institution role is only in funding this study and not in the designing, analyzing, and interpretation of outcomes, collecting the data, and in writing the final manuscript
The diagnostic process typically involves: Clinical history taking, focusing on symptoms (fatigue, neurological changes, dietary habits) Physical examination for signs of anaemia or neurological impairment Blood tests including full blood count, serum B12, and often folate levels Additional investigations such as intrinsic factor antibodies or parietal cell antibodies if pernicious anaemia is suspected For borderline results, additional tests like holotranscobalamin (active B12) may be considered NICE guidance recommends that treatment should commence based on clinical presentation if neurological symptoms are present, without waiting for laboratory confirmation, as delays can result in irreversible nerve damage
As the water mixes with the powder, it forms a liquid jelly that is applied to the area
In March 2024, we announced positive results from this Phase 1 MAD clinical trial of the oral tablet formulation of VK2735
